Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0045785,GO:0045785,positive regulation of cell adhesion,27/126,446/18800,1.66273124416123e-18,3.2767925002795503e-15,2.00782607272732e-15,B2M/CD27/CD276/CD46/CD80/CD83/CSF1/CXCL13/EPO/FBLN2/FSTL3/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/ITGAV/LGALS9/LILRB4/PLAUR/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1/VEGFA,27
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,23/126,291/18800,2.1480121273546698e-18,3.2767925002795503e-15,2.00782607272732e-15,B2M/CD27/CD276/CD46/CD80/CD83/CXCL13/EPO/FSTL3/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/PLAUR/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1,23
GO:0050870,GO:0050870,positive regulation of T cell activation,20/126,223/18800,3.62007073631316e-17,3.68161193883049e-14,2.25587565883936e-14,B2M/CD27/CD276/CD46/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1,20
GO:0032944,GO:0032944,regulation of mononuclear cell proliferation,20/126,233/18800,8.570249231464641e-17,6.53695760129965e-14,4.00546385133716e-14,CD276/CD46/CD80/CSF1/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/ST6GAL1/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,20
GO:0050863,GO:0050863,regulation of T cell activation,22/126,342/18800,9.80270322964408e-16,3.73850594420551e-13,2.29073696524314e-13,B2M/CD27/CD276/CD46/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/TNFRSF1B/VCAM1/VSIG4,22
GO:0050867,GO:0050867,positive regulation of cell activation,24/126,436/18800,1.4124220260033802e-15,4.788110668151449e-13,2.9338731206807e-13,ACTA2/B2M/CD27/CD276/CD46/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LBP/LGALS9/LILRB4/NECTIN2/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/TNFRSF4/VCAM1,24
GO:0042098,GO:0042098,T cell proliferation,18/126,204/18800,2.0446112876852802e-15,5.67100821702525e-13,3.4748609061521997e-13,CD276/CD46/CD80/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,18
GO:0042129,GO:0042129,regulation of T cell proliferation,17/126,174/18800,2.34391123748914e-15,5.95939432131613e-13,3.65156698050939e-13,CD276/CD46/CD80/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/VCAM1/VSIG4,17
GO:0032943,GO:0032943,mononuclear cell proliferation,20/126,300/18800,1.1304192980441201e-14,2.29927285222174e-12,1.40885941987815e-12,CD276/CD46/CD80/CSF1/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/ST6GAL1/TFRC/TGFBR2/TNFRSF14/TNFRSF1B/TNFRSF4/VCAM1/VSIG4,20
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,21/126,381/18800,9.84854082142903e-14,1.5023949023090002e-11,9.20579394676734e-12,B2M/CD27/CD276/CD46/CD80/CD83/EPO/HAVCR2/HLA-E/IGFBP2/IL2RA/IL6/LGALS9/LILRB4/SIRPB1/TFRC/TGFBR2/THY1/TNFRSF14/VCAM1/VSIG4,21
GO:0002687,GO:0002687,positive regulation of leukocyte migration,12/126,141/18800,1.85187382918036e-10,2.35419460534553e-08,1.44251224588786e-08,CCL20/CSF1/CXCL13/F7/IL6/LBP/LGALS9/PGF/PTN/THY1/TNFRSF14/VEGFA,12
GO:0002697,GO:0002697,regulation of immune effector process,17/126,353/18800,2.20232204601252e-10,2.68771382495368e-08,1.64687324367084e-08,B2M/CD46/CD59/CD80/HAVCR2/HLA-E/IL6/LBP/LGALS9/LILRB4/NECTIN2/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4/VSIG4,17
GO:0046718,GO:0046718,viral entry into host cell,12/126,146/18800,2.78198752719826e-10,3.14364590573403e-08,1.92624165625891e-08,CD46/CD80/CLEC5A/EPHA2/ITGAV/LGALS9/NECTIN2/NECTIN4/SCARB2/TFRC/TNFRSF14/TNFRSF4,12
GO:0060326,GO:0060326,cell chemotaxis,16/126,315/18800,3.57865181239954e-10,3.8994523855825e-08,2.38935549579759e-08,CCL14/CCL20/CCN3/CHGA/CSF1/CXCL13/EPHA2/F7/IL6/LBP/LGALS9/NBL1/PGF/PTN/VCAM1/VEGFA,16
GO:0002274,GO:0002274,myeloid leukocyte activation,14/126,232/18800,5.207234635414e-10,5.29575762421604e-08,3.24492937280536e-08,CD93/CHGA/CSF1/HAVCR2/IFNGR1/IL6/LBP/LGALS9/LILRB4/LTBR/NECTIN2/PLA2G2A/TGFBR2/VSIG4,14
GO:0050900,GO:0050900,leukocyte migration,17/126,384/18800,8.006710575104951e-10,7.4025678680743e-08,4.53585900522692e-08,CCL14/CCL20/CCN3/CHGA/CSF1/CXCL13/F7/IL6/LBP/LGALS9/NBL1/PGF/PTN/THY1/TNFRSF14/VCAM1/VEGFA,17
GO:0001819,GO:0001819,positive regulation of cytokine production,17/126,475/18800,1.92251572539839e-08,1.58529607518661e-06,9.71376366517079e-07,B2M/BTN3A2/CD14/CD276/CD46/CD80/CD83/CLEC5A/HAVCR2/HLA-E/IFNGR1/IL6/LBP/LGALS9/SPON2/TNFRSF14/TNFRSF8,17
GO:0042742,GO:0042742,defense response to bacterium,15/126,364/18800,2.21896374013705e-08,1.78159430819951e-06,1.09165639957989e-06,CCL20/CHGA/COLEC12/CXCL13/EPHA2/HAVCR2/HLA-E/IL6/LBP/PLA2G2A/RNASE6/SPON2/TNFRSF14/TNFRSF1A/WFDC2,15
GO:0043410,GO:0043410,positive regulation of MAPK cascade,17/126,491/18800,3.11796715361088e-08,2.3782294464167e-06,1.45723938547709e-06,ACTA2/CCL14/CCL20/CD27/EDA2R/EFNA1/EPO/FGF23/GDF15/HAVCR2/IGFBP4/IL6/LGALS9/LTBR/PLA2G2A/TNFRSF19/VEGFA,17
GO:0050920,GO:0050920,regulation of chemotaxis,12/126,225/18800,3.77775424562973e-08,2.74426861986103e-06,1.68152670181414e-06,CCN3/CSF1/CXCL13/F7/IL6/LBP/LGALS9/NBL1/PGF/PTN/ST6GAL1/VEGFA,12
GO:0007565,GO:0007565,female pregnancy,11/126,185/18800,4.73368768721613e-08,3.28238207584009e-06,2.01125103648226e-06,ADM/EPO/HAVCR2/IGFBP2/IGFBP7/LGALS9/PGF/PTN/TGFBR2/TIMP1/VEGFA,11
GO:0002507,GO:0002507,tolerance induction,6/126,31/18800,5.16013522183356e-08,3.49857168040315e-06,2.14371933426348e-06,HAVCR2/HLA-E/IL2RA/LGALS9/LILRB4/TGFBR2,6
GO:0002819,GO:0002819,regulation of adaptive immune response,11/126,188/18800,5.58276467827867e-08,3.69629872265773e-06,2.26487485774815e-06,B2M/CD46/CD80/HAVCR2/HLA-E/IL6/LILRB4/NECTIN2/TFRC/TNFRSF14/TNFRSF1B,11
GO:0030099,GO:0030099,myeloid cell differentiation,15/126,391/18800,5.69406882874183e-08,3.69629872265773e-06,2.26487485774815e-06,B2M/BGLAP/CLEC5A/CSF1/DLL1/EPHA2/EPO/FSTL3/LILRB4/LTBR/OSCAR/TFRC/TGFBR2/TGFBR3/VEGFA,15
GO:0002237,GO:0002237,response to molecule of bacterial origin,14/126,354/18800,1.11945834517227e-07,6.97034165534816e-06,4.27101615687638e-06,ADM/B2M/CD14/CD80/CXCL13/EPO/HAVCR2/IL18BP/IL6/LBP/LGALS9/SPON2/TNFRSF1B/VCAM1,14
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,16/126,486/18800,1.62862137146332e-07,9.74298785163646e-06,5.96993097155595e-06,CCL14/CCL20/CSF1/CXCL13/EDA2R/EPO/IFNGR1/IL2RA/IL6/LILRB4/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/YAP1,16
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,14/126,370/18800,1.92165100836077e-07,1.12198449460224e-05,6.87486229679168e-06,B2M/BTN3A2/CD27/CD46/CD80/CXCL13/HAVCR2/HLA-E/IL18BP/IL6/LILRB4/NECTIN2/TFRC/TNFRSF1B,14
GO:0044706,GO:0044706,multi-multicellular organism process,11/126,213/18800,1.98420855517813e-07,1.12198449460224e-05,6.87486229679168e-06,ADM/EPO/HAVCR2/IGFBP2/IGFBP7/LGALS9/PGF/PTN/TGFBR2/TIMP1/VEGFA,11
GO:1903706,GO:1903706,regulation of hemopoiesis,14/126,371/18800,1.98581326478273e-07,1.12198449460224e-05,6.87486229679168e-06,B2M/BGLAP/CD27/CD46/CD80/CD83/CSF1/DLL1/FSTL3/IL2RA/LGALS9/LILRB4/PTN/TGFBR2,14
GO:0045582,GO:0045582,positive regulation of T cell differentiation,8/126,94/18800,2.23658376265913e-07,1.21853876069161e-05,7.4664901550425e-06,CD27/CD46/CD80/CD83/IL2RA/LGALS9/LILRB4/TGFBR2,8
GO:0048771,GO:0048771,tissue remodeling,10/126,174/18800,2.71951146947958e-07,1.43055680920383e-05,8.76561228638064e-06,ACVRL1/BGLAP/CST3/CTHRC1/EPHA2/IL6/PTN/RSPO3/TFRC/TIMP1,10
GO:0032640,GO:0032640,tumor necrosis factor production,10/126,182/18800,4.12368896281009e-07,1.9355961577744e-05,1.18601969197583e-05,CD14/HAVCR2/HLA-E/IFNGR1/IL6/LBP/LGALS9/LILRB4/SPON2/TNFRSF8,10
GO:0002443,GO:0002443,leukocyte mediated immunity,15/126,457/18800,4.24525869194921e-07,1.95006151326962e-05,1.1948832126022e-05,B2M/BTN3A2/CD27/CD46/CHGA/HAVCR2/HLA-E/IL6/LGALS9/LILRB4/NECTIN2/SPON2/TFRC/TNFRSF1B/ULBP2,15
GO:0031099,GO:0031099,regeneration,10/126,188/18800,5.55955993707123e-07,2.38904469971892e-05,1.46386633776701e-05,ADM/CCN3/F7/IL6/PGF/PTN/TGFBR2/TGFBR3/THY1/YAP1,10
GO:0006898,GO:0006898,receptor-mediated endocytosis,11/126,246/18800,8.32696674843433e-07,3.48021582869495e-05,2.13247194595809e-05,ADM/B2M/CD14/DLL1/HSPG2/ITGAV/LILRB4/SCARB2/TFRC/TGFBR2/VEGFA,11
GO:0002456,GO:0002456,T cell mediated immunity,8/126,112/18800,8.64025281393952e-07,3.56235288315263e-05,2.18280071088998e-05,B2M/BTN3A2/CD46/HLA-E/IL6/LILRB4/NECTIN2/TNFRSF1B,8
GO:0034612,GO:0034612,response to tumor necrosis factor,11/126,249/18800,9.3811942850756e-07,3.81626983516875e-05,2.338386112322e-05,CCL14/CCL20/CD14/EDA2R/IL18BP/TNFRSF14/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/VCAM1,11
GO:0001570,GO:0001570,vasculogenesis,7/126,80/18800,1.08748777262717e-06,4.25375024908399e-05,2.60644842670157e-05,ADM/EPHA2/ITGAV/TGFBR2/TGFBR3/VEGFA/YAP1,7
GO:0042060,GO:0042060,wound healing,14/126,429/18800,1.13278657557059e-06,4.26682943464924e-05,2.61446258377307e-05,ACTA2/ACVRL1/CD59/F10/F7/IL6/OCLN/PLAUR/PROS1/TGFBR2/TIMP1/TNFRSF12A/VEGFA/YAP1,14
GO:0032103,GO:0032103,positive regulation of response to external stimulus,14/126,442/18800,1.60933956026849e-06,5.77658235103432e-05,3.53955053750693e-05,CSF1/CXCL13/F7/HAVCR2/HLA-E/IL6/LBP/LGALS9/NECTIN2/PGF/PLA2G2A/PTN/TNFRSF1A/VEGFA,14
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,9/126,167/18800,1.87915606920702e-06,6.59000593925358e-05,4.03796875851381e-05,B2M/HLA-E/IL6/LILRB4/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0001666,GO:0001666,response to hypoxia,11/126,286/18800,3.60014658228381e-06,0.0001195311344407,7.32416618422722e-05,ACVRL1/ADM/EPO/F7/HYOU1/PGF/TFRC/TGFBR2/TGFBR3/VCAM1/VEGFA,11
GO:0045765,GO:0045765,regulation of angiogenesis,12/126,345/18800,3.60434754786858e-06,0.0001195311344407,7.32416618422722e-05,ACVRL1/ADAM12/ADM/CXCL13/DLL1/EFNA1/EPHA2/HSPG2/IL6/PGF/TGFBR2/VEGFA,12
GO:0031100,GO:0031100,animal organ regeneration,6/126,65/18800,4.80614985457897e-06,0.0001466356320632,8.98497067550763e-05,ADM/F7/IL6/PGF/TGFBR2/TGFBR3,6
GO:0002367,GO:0002367,cytokine production involved in immune response,7/126,100/18800,4.90561808115755e-06,0.0001481885224317,9.08012268070433e-05,B2M/HLA-E/IL6/LILRB4/SPON2/TNFRSF14/TNFRSF1B,7
GO:0001503,GO:0001503,ossification,13/126,420/18800,4.98119140003232e-06,0.0001489962251127,9.12961395919237e-05,BGLAP/CHRDL1/CLEC5A/CRIM1/CSF1/CTHRC1/EPHA2/FGF23/FSTL3/IL6/PTN/TNC/YAP1,13
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,10/126,251/18800,7.46807041081336e-06,0.0002149536115414,0.0001317109538193,CD27/COL6A3/CRIM1/CST3/ITIH3/PLAUR/PROS1/TIMP1/VEGFA/WFDC2,10
GO:0007584,GO:0007584,response to nutrient,8/126,150/18800,7.72817072256665e-06,0.000220361204435,0.0001350244092796,BGLAP/EPO/F7/FGF23/IGFBP2/TFRC/TGFBR2/VCAM1,8
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,12/126,373/18800,7.96764615712925e-06,0.0002230209947284,0.0001366541726225,CD80/EFEMP1/EFNA1/EPHA2/EPHB4/EPO/IL6/LILRB4/THY1/TNFRSF14/TNFRSF1A/VEGFA,12
GO:0003007,GO:0003007,heart morphogenesis,10/126,254/18800,8.28755691698747e-06,0.0002277958212047,0.0001395799059703,ACVRL1/DLL1/EFNA1/EPHB4/FLRT2/NRP2/TGFBR2/TGFBR3/VEGFA/YAP1,10
GO:0009612,GO:0009612,response to mechanical stimulus,9/126,201/18800,8.5477297261972e-06,0.0002311515373006,0.000141636091789,BGLAP/IGFBP2/LRP11/LTBR/PTN/TGFBR2/TNFRSF10B/TNFRSF1A/TNFRSF8,9
GO:0006959,GO:0006959,humoral immune response,11/126,317/18800,9.56033279155576e-06,0.0002536397856264,0.00015541557014,CD46/CD59/CD83/CXCL13/HLA-E/IL6/RNASE6/SPON2/ST6GAL1/VSIG4/WFDC2,11
GO:0046631,GO:0046631,alpha-beta T cell activation,8/126,158/18800,1.13104450854775e-05,0.0002875680662982,0.0001762048287,CD80/CD83/HLA-E/IL6/LGALS9/LILRB4/TGFBR2/TNFRSF14,8
GO:0007568,GO:0007568,aging,8/126,163/18800,1.41925172649059e-05,0.0003492045981873,0.000213972076931,ADM/EPO/IGFBP2/TFRC/TGFBR2/TIMP1/TNFRSF1B/VCAM1,8
GO:0048872,GO:0048872,homeostasis of number of cells,10/126,282/18800,2.05139722158509e-05,0.0004928199152012,0.0003019711119382,B2M/CCN3/CSF1/EPO/IL2RA/IL6/LGALS9/PLA2G2A/TGFBR3/VEGFA,10
GO:0002709,GO:0002709,regulation of T cell mediated immunity,6/126,88/18800,2.7811952190094e-05,0.0006351562202774,0.0003891864435173,B2M/HLA-E/IL6/LILRB4/NECTIN2/TNFRSF1B,6
GO:0097305,GO:0097305,response to alcohol,9/126,235/18800,2.9616885169214e-05,0.0006677682211805,0.0004091691631101,BGLAP/CD14/CD27/F7/IGFBP7/ST6GAL1/TGFBR2/TGFBR3/VCAM1,9
GO:0052548,GO:0052548,regulation of endopeptidase activity,12/126,426/18800,2.97661350640959e-05,0.0006677682211805,0.0004091691631101,CD27/COL6A3/CRIM1/CST3/EFNA1/ITIH3/LGALS9/PLAUR/PROS1/TIMP1/VEGFA/WFDC2,12
GO:0007219,GO:0007219,Notch signaling pathway,8/126,182/18800,3.14185534945469e-05,0.0006946232370424,0.0004256243402464,CCN3/CD46/DLL1/DTX3/IL2RA/NOTCH3/TGFBR2/YAP1,8
GO:0032102,GO:0032102,negative regulation of response to external stimulus,12/126,429/18800,3.18733918066107e-05,0.0006996094849062,0.0004286796202085,CCN3/CXCL13/HAVCR2/HLA-E/IL2RA/LGALS9/NBL1/PROS1/ST6GAL1/TNFRSF1A/TNFRSF1B/VSIG4,12
GO:0001906,GO:0001906,cell killing,8/126,185/18800,3.53059602167569e-05,0.0007639608838391,0.0004681103795816,B2M/CD59/CHGA/HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,8
GO:0001649,GO:0001649,osteoblast differentiation,9/126,241/18800,3.60735506143236e-05,0.00077031490849,0.0004720037528604,BGLAP/CLEC5A/CRIM1/CTHRC1/EPHA2/FGF23/IL6/TNC/YAP1,9
GO:0090130,GO:0090130,tissue migration,11/126,366/18800,3.61045663435182e-05,0.00077031490849,0.0004720037528604,ACTA2/ACVRL1/CCN3/CXCL13/EFNA1/EPHA2/EPHB4/NRP2/PTN/TGFBR2/VEGFA,11
GO:0050673,GO:0050673,epithelial cell proliferation,12/126,443/18800,4.35166135330087e-05,0.0009093779992411,0.0005572134508624,ACVRL1/B2M/CCN3/EPHA2/IGFBP4/IL6/NRP2/PGF/PTN/TGFBR3/VEGFA/YAP1,12
GO:0031341,GO:0031341,regulation of cell killing,6/126,100/18800,5.73019060355112e-05,0.0011239613369016,0.0006886975225853,B2M/CD59/HAVCR2/HLA-E/LGALS9/NECTIN2,6
GO:0033028,GO:0033028,myeloid cell apoptotic process,4/126,32/18800,5.981045381943e-05,0.0011549474341967,0.0007076839838994,CLEC5A/EPO/IL6/ST6GAL1,4
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,3/126,13/18800,8.00433771927026e-05,0.0014450434545262,0.0008854377944206,CST3/TNFRSF1A/TNFRSF1B,3
GO:0035633,GO:0035633,maintenance of blood-brain barrier,4/126,35/18800,8.57450474062821e-05,0.0015252097451029,0.0009345589909444,ESAM/IL6/OCLN/VEGFA,4
GO:0071887,GO:0071887,leukocyte apoptotic process,6/126,109/18800,9.26855570426563e-05,0.0015914920806641,0.0009751729149233,CD27/EFNA1/IL2RA/IL6/LGALS9/ST6GAL1,6
GO:0043627,GO:0043627,response to estrogen,5/126,68/18800,9.28500787801458e-05,0.0015914920806641,0.0009751729149233,BGLAP/EPO/F7/IGFBP2/TGFBR2,5
GO:0001667,GO:0001667,ameboidal-type cell migration,12/126,480/18800,9.35794897213659e-05,0.0015950336488261,0.0009773429799773,ACTA2/ACVRL1/CCN3/CXCL13/EFNA1/EPHA2/EPHB4/NRP2/PTN/TGFBR2/TIMP1/VEGFA,12
GO:0033033,GO:0033033,negative regulation of myeloid cell apoptotic process,3/126,14/18800,0.000101374866312,0.0017183039839898,0.0010528758045044,CLEC5A/EPO/ST6GAL1,3
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,7/126,161/18800,0.000106653109603,0.0017749132263076,0.0010875626248244,CD80/HAVCR2/IL2RA/LGALS9/LILRB4/TNFRSF14/VSIG4,7
GO:0002526,GO:0002526,acute inflammatory response,6/126,113/18800,0.0001131498815818,0.0018362781314167,0.001125163436111,EPO/HLA-E/IL6/LBP/TFRC/VCAM1,6
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,5/126,72/18800,0.0001219924112757,0.0019385356604282,0.001187820846632,HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,5
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,8/126,221/18800,0.0001229139106151,0.0019430587631442,0.0011905923384375,CD27/ITGAV/LTBR/TNFRSF10B/TNFRSF12A/TNFRSF1A/TNFRSF1B/YAP1,8
GO:0002366,GO:0002366,leukocyte activation involved in immune response,9/126,285/18800,0.0001306025952846,0.0020407239823167,0.0012504358510909,CD46/CD80/CHGA/DLL1/HAVCR2/IL6/LBP/LGALS9/TFRC,9
GO:0002477,GO:0002477,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,2/126,3/18800,0.0001331052351625,0.0020407239823167,0.0012504358510909,B2M/HLA-E,2
GO:0014028,GO:0014028,notochord formation,2/126,3/18800,0.0001331052351625,0.0020407239823167,0.0012504358510909,EFNA1/EPHA2,2
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,5/126,74/18800,0.000138961157472,0.0020988638190462,0.0012860605298094,DLL1/NRP2/PGF/VCAM1/VEGFA,5
GO:0048639,GO:0048639,positive regulation of developmental growth,7/126,169/18800,0.0001442120198885,0.0021568180033326,0.0013215714516099,AGRN/CSF1/DLL1/TGFBR2/TGFBR3/VEGFA/YAP1,7
GO:0071772,GO:0071772,response to BMP,7/126,173/18800,0.0001666575547595,0.0023760383157543,0.0014558967892424,ACVRL1/CHRDL1/CRIM1/FSTL3/GDF15/NBL1/TGFBR3,7
GO:0022612,GO:0022612,gland morphogenesis,6/126,123/18800,0.0001802278235101,0.0025339865876939,0.0015526782175799,CSF1/EPHA2/IL6/PTN/TGFBR2/TNC,6
GO:0007411,GO:0007411,axon guidance,8/126,234/18800,0.0001819419324273,0.0025463524579621,0.0015602552969141,EFNA1/EFNA4/EPHA2/EPHB4/FLRT2/NOTCH3/NRP2/VEGFA,8
GO:0051346,GO:0051346,negative regulation of hydrolase activity,10/126,371/18800,0.0002009841062523,0.0027746719826966,0.0017001560976622,CD27/COL6A3/CRIM1/CST3/ITIH3/PLAUR/PROS1/TIMP1/VEGFA/WFDC2,10
GO:0050852,GO:0050852,T cell receptor signaling pathway,6/126,127/18800,0.000214528879128,0.0029351013911196,0.0017984578207761,BTN2A1/BTN3A2/CD276/LILRB4/NECTIN2/THY1,6
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,7/126,185/18800,0.0002514811576041,0.0033343338176375,0.0020430840139123,ADM/CSF1/EPHA2/RSPO3/TGFBR2/VEGFA/YAP1,7
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,4/126,46/18800,0.0002524520196244,0.0033343338176375,0.0020430840139123,HAVCR2/HLA-E/LGALS9/NECTIN2,4
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,6/126,131/18800,0.0002537816973837,0.0033374480979212,0.0020449922620394,B2M/HAVCR2/HLA-E/LGALS9/NECTIN2/ULBP2,6
GO:0002440,GO:0002440,production of molecular mediator of immune response,9/126,312/18800,0.0002564655693748,0.003358268035033,0.0020577494972204,B2M/HLA-E/IL6/LILRB4/SPON2/TFRC/TNFRSF14/TNFRSF1B/TNFRSF4,9
GO:0002040,GO:0002040,sprouting angiogenesis,7/126,186/18800,0.0002598808938521,0.0033884470390728,0.00207624141917,ACVRL1/DLL1/EPHA2/EPHB4/PGF/RSPO3/VEGFA,7
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,2/126,4/18800,0.0002650403746914,0.0034119754564706,0.0020906582520629,TNFRSF1A/TNFRSF1B,2
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,5/126,85/18800,0.0002668381635976,0.0034206858703211,0.0020959954823061,B2M/HAVCR2/HLA-E/LGALS9/NECTIN2,5
GO:0033627,GO:0033627,cell adhesion mediated by integrin,5/126,86/18800,0.0002818039092454,0.0035974214523342,0.0022042886713055,CCN3/CXCL13/EFNA1/EPHA2/ITGAV,5
GO:0060249,GO:0060249,anatomical structure homeostasis,9/126,319/18800,0.0003019171051261,0.0037752011792616,0.0023132216510095,B2M/BGLAP/CSF1/ESAM/IL6/OCLN/TFRC/VEGFA/YAP1,9
GO:0071216,GO:0071216,cellular response to biotic stimulus,8/126,256/18800,0.0003338993981922,0.004107770418889,0.002517000556831,CD14/CD80/CXCL13/HAVCR2/IL6/LBP/SPON2/TNFRSF1B,8
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,4/126,50/18800,0.0003489951239713,0.0041936851011138,0.0025696440302845,ACVRL1/DLL1/VEGFA/YAP1,4
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,4/126,50/18800,0.0003489951239713,0.0041936851011138,0.0025696440302845,DLL1/NRP2/PGF/VEGFA,4
GO:0051384,GO:0051384,response to glucocorticoid,6/126,139/18800,0.0003491301264119,0.0041936851011138,0.0025696440302845,ADM/BGLAP/EPO/IGFBP2/IGFBP7/IL6,6
GO:0001763,GO:0001763,morphogenesis of a branching structure,7/126,199/18800,0.0003911677342434,0.0045902029122187,0.0028126068664632,ADM/CSF1/EPHA2/RSPO3/TGFBR2/VEGFA/YAP1,7
GO:0048013,GO:0048013,ephrin receptor signaling pathway,4/126,52/18800,0.0004060408428572,0.0047311707941093,0.0028989837086505,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/126,5/18800,0.0004397933664827,0.0050255039743032,0.0030793338019847,TNFRSF1A/TNFRSF1B,2
GO:0031348,GO:0031348,negative regulation of defense response,8/126,268/18800,0.0004529159527462,0.0051561439247347,0.0031593822940982,CCN3/HAVCR2/HLA-E/IL2RA/LGALS9/TNFRSF1A/TNFRSF1B/VSIG4,8
GO:0036303,GO:0036303,lymph vessel morphogenesis,3/126,23/18800,0.0004719559291015,0.0053331019988478,0.0032678118131945,ACVRL1/EPHA2/VEGFA,3
GO:0044089,GO:0044089,positive regulation of cellular component biogenesis,11/126,494/18800,0.0004949756922104,0.0055725861141479,0.003414553619599,AGRN/CHGA/CXCL13/EPHA2/FLRT2/LMOD1/OCLN/PALM/TFRC/THY1/VEGFA,11
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/126,6/18800,0.000656793440288,0.0071233662659817,0.00436478065462,HAVCR2/LGALS9,2
GO:1901890,GO:1901890,positive regulation of cell junction assembly,5/126,105/18800,0.0007061927073388,0.0074812289933707,0.0045840579248309,AGRN/EPHA2/FLRT2/THY1/VEGFA,5
GO:0010632,GO:0010632,regulation of epithelial cell migration,8/126,290/18800,0.0007596982115217,0.0080047912610033,0.0049048661455405,ACVRL1/CXCL13/EFNA1/EPHA2/NRP2/PTN/TGFBR2/VEGFA,8
GO:0031589,GO:0031589,cell-substrate adhesion,9/126,364/18800,0.0007811616268399,0.008134212025559,0.0049841675921243,ACVRL1/CSF1/EFNA1/FBLN2/ITGAV/ST6GAL1/THY1/VCAM1/VEGFA,9
GO:0043030,GO:0043030,regulation of macrophage activation,4/126,62/18800,0.0007946211819983,0.0081629266878013,0.0050017622513878,HAVCR2/IL6/LBP/VSIG4,4
GO:1903034,GO:1903034,regulation of response to wounding,6/126,166/18800,0.0008907443828037,0.0089607830483788,0.0054906417892048,ACTA2/F7/OCLN/PROS1/PTN/TNFRSF12A,6
GO:0003170,GO:0003170,heart valve development,4/126,65/18800,0.0009496222058876,0.0092862094556509,0.0056900439866949,EFNA1/TGFBR2/TNFRSF1A/TNFRSF1B,4
GO:0060485,GO:0060485,mesenchyme development,8/126,301/18800,0.0009662183380284,0.0094183135761175,0.0057709896362485,ACTA2/ACVRL1/EFNA1/IL6/NRP2/TGFBR2/TGFBR3/YAP1,8
GO:0090288,GO:0090288,negative regulation of cellular response to growth factor stimulus,5/126,115/18800,0.0010643725613501,0.0101111648895458,0.006195528245729,CHRDL1/CRIM1/CXCL13/FSTL3/NBL1,5
GO:0006909,GO:0006909,phagocytosis,8/126,310/18800,0.0011667575985827,0.0108529799794995,0.0066500689829361,CD14/CD302/CD93/COLEC12/ITGAV/LBP/SIRPB1/SPON2,8
GO:1905603,GO:1905603,regulation of blood-brain barrier permeability,2/126,8/18800,0.0012152798150651,0.0110681155694443,0.0067818914424375,OCLN/VEGFA,2
GO:0071260,GO:0071260,cellular response to mechanical stimulus,4/126,70/18800,0.0012533759974445,0.0113137578940923,0.0069324066379988,LTBR/TNFRSF10B/TNFRSF1A/TNFRSF8,4
GO:0010743,GO:0010743,regulation of macrophage derived foam cell differentiation,3/126,32/18800,0.0012649390923887,0.0113266502571257,0.0069403063211907,CSF1/ITGAV/PLA2G2A,3
GO:0042246,GO:0042246,tissue regeneration,4/126,72/18800,0.0013919436277694,0.0123096232125348,0.0075426144406361,CCN3/PTN/TGFBR2/YAP1,4
GO:0070232,GO:0070232,regulation of T cell apoptotic process,3/126,34/18800,0.0015112739801831,0.0131957120748376,0.0080855576756237,CD27/EFNA1/LGALS9,3
GO:1904238,GO:1904238,pericyte cell differentiation,2/126,9/18800,0.0015556524918139,0.0132949460855028,0.0081463624516044,ACTA2/EPHA2,2
GO:0045927,GO:0045927,positive regulation of growth,7/126,256/18800,0.0017083006227576,0.0144336404893454,0.0088440875326734,AGRN/CSF1/DLL1/TGFBR2/TGFBR3/VEGFA/YAP1,7
GO:0061448,GO:0061448,connective tissue development,7/126,260/18800,0.0018652536183423,0.0155065089633857,0.0095014783484182,ACTA2/ACVRL1/CCN3/CSF1/EFEMP1/TGFBR2/TIMP1,7
GO:0010742,GO:0010742,macrophage derived foam cell differentiation,3/126,38/18800,0.0020894079924897,0.0167643059487115,0.0102721824992363,CSF1/ITGAV/PLA2G2A,3
GO:0097084,GO:0097084,vascular associated smooth muscle cell development,2/126,11/18800,0.002355913914136,0.0185155501886892,0.0113452421587787,ADM/VEGFA,2
GO:0002064,GO:0002064,epithelial cell development,6/126,203/18800,0.0024801611745857,0.0192543810271274,0.0117979543218542,ACTA2/DLL1/EPHA2/TNFRSF1A/VEGFA/YAP1,6
GO:0070555,GO:0070555,response to interleukin-1,5/126,141/18800,0.0026121368986129,0.0199740092172135,0.012238900229354,CCL14/CCL20/EPO/IL6/LGALS9,5
GO:0034103,GO:0034103,regulation of tissue remodeling,4/126,86/18800,0.0026738668200168,0.0203949191696783,0.0124968091377628,BGLAP/CST3/IL6/TFRC,4
GO:0051602,GO:0051602,response to electrical stimulus,3/126,42/18800,0.0027885211265328,0.0209456489710648,0.0128342640282258,CD14/EPO/PALM,3
GO:0071354,GO:0071354,cellular response to interleukin-6,3/126,42/18800,0.0027885211265328,0.0209456489710648,0.0128342640282258,FGF23/IL6/YAP1,3
GO:0033690,GO:0033690,positive regulation of osteoblast proliferation,2/126,12/18800,0.0028147217561902,0.0209456489710648,0.0128342640282258,CTHRC1/ITGAV,2
GO:0050729,GO:0050729,positive regulation of inflammatory response,5/126,145/18800,0.0029472819210941,0.0218256241292673,0.0133734611442594,HLA-E/IL6/LBP/PLA2G2A/TNFRSF1A,5
GO:0072006,GO:0072006,nephron development,5/126,145/18800,0.0029472819210941,0.0218256241292673,0.0133734611442594,ACTA2/DLL1/NOTCH3/VEGFA/YAP1,5
GO:0014002,GO:0014002,astrocyte development,3/126,43/18800,0.0029831175280985,0.0219842791744656,0.0134706756417571,DLL1/IFNGR1/IL6,3
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,6/126,211/18800,0.0030039295784007,0.0220843111896401,0.0135319693880525,ACVRL1/NRP2/PGF/PTN/VEGFA/YAP1,6
GO:0050767,GO:0050767,regulation of neurogenesis,8/126,361/18800,0.0030150038368122,0.0221124440050822,0.0135492075257555,B2M/DLL1/IL6/PTN/THY1/TNFRSF1B/VEGFA/YAP1,8
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,2/126,13/18800,0.0033119360069171,0.0237199923875684,0.0145342187998142,CST3/IL6,2
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,2/126,13/18800,0.0033119360069171,0.0237199923875684,0.0145342187998142,ADM/RSPO3,2
GO:0070741,GO:0070741,response to interleukin-6,3/126,46/18800,0.0036162592901008,0.0253636944691903,0.0155413829382194,FGF23/IL6/YAP1,3
GO:0007596,GO:0007596,blood coagulation,6/126,221/18800,0.0037701385686366,0.0261409512184896,0.0160176402435914,CD59/F10/F7/IL6/PLAUR/PROS1,6
GO:0048592,GO:0048592,eye morphogenesis,5/126,154/18800,0.0038134732915309,0.0261409512184896,0.0160176402435914,DLL1/EFEMP1/EPHA2/THY1/VEGFA,5
GO:0050919,GO:0050919,negative chemotaxis,3/126,47/18800,0.0038441055674632,0.0261409512184896,0.0160176402435914,FLRT2/ITGAV/NRP2,3
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/126,14/18800,0.0038470295303513,0.0261409512184896,0.0160176402435914,TNFRSF1A/TNFRSF1B,2
GO:0033628,GO:0033628,regulation of cell adhesion mediated by integrin,3/126,48/18800,0.0040805174943504,0.0274221561129145,0.0168026873868917,CXCL13/EFNA1/EPHA2,3
GO:0045807,GO:0045807,positive regulation of endocytosis,4/126,97/18800,0.0041237462599577,0.0275307436304838,0.0168692234427847,B2M/CD14/DLL1/VEGFA,4
GO:0050817,GO:0050817,coagulation,6/126,226/18800,0.0042035888171765,0.0279415021377027,0.0171209121415101,CD59/F10/F7/IL6/PLAUR/PROS1,6
GO:0050878,GO:0050878,regulation of body fluid levels,8/126,382/18800,0.0042391715496828,0.0280557752669901,0.0171909320064774,ADM/CD59/F10/F7/IL6/PLAUR/PROS1/VEGFA,8
GO:0060043,GO:0060043,regulation of cardiac muscle cell proliferation,3/126,49/18800,0.0043255900822334,0.0283205479418328,0.017353169157548,TGFBR2/TGFBR3/YAP1,3
GO:0052372,GO:0052372,modulation by symbiont of entry into host,3/126,50/18800,0.0045794152923352,0.0295386808814266,0.0180995695097082,ITGAV/LGALS9/NECTIN2,3
GO:0071496,GO:0071496,cellular response to external stimulus,7/126,309/18800,0.0048408769989537,0.0309633453329305,0.0189725202474718,BGLAP/FGF23/LTBR/TNFRSF10B/TNFRSF1A/TNFRSF8/VCAM1,7
GO:0033002,GO:0033002,muscle cell proliferation,6/126,233/18800,0.0048710164855129,0.031090944136611,0.0190507053033936,CCN3/IL6/NOTCH3/TGFBR2/TGFBR3/YAP1,6
GO:0008228,GO:0008228,opsonization,2/126,16/18800,0.0050287720209716,0.0316999657768275,0.0194238780105386,LBP/SPON2,2
GO:0030002,GO:0030002,cellular anion homeostasis,2/126,16/18800,0.0050287720209716,0.0316999657768275,0.0194238780105386,CKB/FGF23,2
GO:0016049,GO:0016049,cell growth,9/126,484/18800,0.0053354833480816,0.0332894881288284,0.0203978439913744,ACVRL1/CCN3/IGFBP4/IGFBP7/NRP2/TGFBR2/TNC/VEGFA/YAP1,9
GO:0002544,GO:0002544,chronic inflammatory response,2/126,17/18800,0.0056743927490262,0.0345454478399624,0.0211674223684291,CXCL13/VCAM1,2
GO:0019885,GO:0019885,antigen processing and presentation of endogenous peptide antigen via MHC class I,2/126,17/18800,0.0056743927490262,0.0345454478399624,0.0211674223684291,B2M/HLA-E,2
GO:0048532,GO:0048532,anatomical structure arrangement,2/126,17/18800,0.0056743927490262,0.0345454478399624,0.0211674223684291,DLL1/NRP2,2
GO:0090713,GO:0090713,immunological memory process,2/126,17/18800,0.0056743927490262,0.0345454478399624,0.0211674223684291,CD46/TNFRSF14,2
GO:0032526,GO:0032526,response to retinoic acid,4/126,109/18800,0.0062274239284113,0.036384682365414,0.022294397309243,IGFBP2/IGFBP7/TFRC/YAP1,4
GO:0043113,GO:0043113,receptor clustering,3/126,56/18800,0.00629094833916,0.036384682365414,0.022294397309243,AGRN/PTN/THY1,3
GO:0032026,GO:0032026,response to magnesium ion,2/126,18/18800,0.0063558361812559,0.036384682365414,0.022294397309243,CD14/FGF23,2
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/126,18/18800,0.0063558361812559,0.036384682365414,0.022294397309243,COLEC12/HAVCR2,2
GO:0002062,GO:0002062,chondrocyte differentiation,4/126,110/18800,0.0064295291120755,0.036384682365414,0.022294397309243,ACVRL1/CCN3/EFEMP1/TGFBR2,4
GO:0060284,GO:0060284,regulation of cell development,9/126,500/18800,0.0065581210188867,0.036384682365414,0.022294397309243,B2M/DLL1/IL6/PTN/THY1/TNFRSF1A/TNFRSF1B/VEGFA/YAP1,9
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,HLA-E,1
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,CST3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,DLL1,1
GO:0031104,GO:0031104,dendrite regeneration,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,PTN,1
GO:0045584,GO:0045584,negative regulation of cytotoxic T cell differentiation,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,LILRB4,1
GO:0045887,GO:0045887,positive regulation of synaptic assembly at neuromuscular junction,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,AGRN,1
GO:0045919,GO:0045919,positive regulation of cytolysis,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,LBP,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,NECTIN2,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,CST3,1
GO:0060611,GO:0060611,mammary gland fat development,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,CSF1,1
GO:0060739,GO:0060739,mesenchymal-epithelial cell signaling involved in prostate gland development,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,TNC,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,VCAM1,1
GO:0061476,GO:0061476,response to anticoagulant,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,F7,1
GO:0061872,GO:0061872,hepatic stellate cell contraction,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,ACTA2,1
GO:0061873,GO:0061873,regulation of hepatic stellate cell contraction,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,ACTA2,1
GO:0061874,GO:0061874,positive regulation of hepatic stellate cell contraction,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,ACTA2,1
GO:0071283,GO:0071283,cellular response to iron(III) ion,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,B2M,1
GO:0086030,GO:0086030,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,CHGA,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,CSF1,1
GO:1904400,GO:1904400,response to Thyroid stimulating hormone,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,F7,1
GO:1905217,GO:1905217,response to astaxanthin,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,F7,1
GO:2000184,GO:2000184,positive regulation of progesterone biosynthetic process,1/126,1/18800,0.0067021276595747,0.036384682365414,0.022294397309243,ADM,1
GO:0002832,GO:0002832,negative regulation of response to biotic stimulus,4/126,113/18800,0.0070618602470064,0.037600998246739,0.0230396842747704,HAVCR2/HLA-E/LGALS9/VSIG4,4
GO:0031623,GO:0031623,receptor internalization,4/126,113/18800,0.0070618602470064,0.037600998246739,0.0230396842747704,ADM/LILRB4/TFRC/VEGFA,4
GO:0060977,GO:0060977,coronary vasculature morphogenesis,2/126,19/18800,0.0070726009436809,0.037600998246739,0.0230396842747704,TGFBR3/VEGFA,2
GO:0034329,GO:0034329,cell junction assembly,8/126,420/18800,0.0073920893178811,0.0391549731056514,0.0239918688387369,ACVRL1/AGRN/EPHA2/ESAM/FLRT2/OCLN/THY1/VEGFA,8
GO:0046888,GO:0046888,negative regulation of hormone secretion,3/126,60/18800,0.0076172006412625,0.0402077494056953,0.0246369483498128,CCN3/CHGA/FGF23,3
GO:0002837,GO:0002837,regulation of immune response to tumor cell,2/126,20/18800,0.0078241906805862,0.0408046206588013,0.0250026760130522,HAVCR2/NECTIN2,2
GO:1902004,GO:1902004,positive regulation of amyloid-beta formation,2/126,20/18800,0.0078241906805862,0.0408046206588013,0.0250026760130522,EFNA1/IFNGR1,2
GO:0045446,GO:0045446,endothelial cell differentiation,4/126,117/18800,0.0079670849936508,0.0412975163099166,0.0253046935315123,ACVRL1/DLL1/TNFRSF1A/VEGFA,4
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,3/126,61/18800,0.0079725457576338,0.0412975163099166,0.0253046935315123,ITGAV/THY1/VCAM1,3
GO:0031346,GO:0031346,positive regulation of cell projection organization,7/126,341/18800,0.0081574865140922,0.0421838836516874,0.0258478074023691,AGRN/EPO/OCLN/PALM/PTN/SCARB2/VEGFA,7
GO:0030278,GO:0030278,regulation of ossification,4/126,118/18800,0.0082047293173323,0.0423563944960763,0.0259535119201751,BGLAP/CSF1/FGF23/PTN,4
GO:0002834,GO:0002834,regulation of response to tumor cell,2/126,22/18800,0.0094298844834405,0.0465538311595258,0.028525454687615,HAVCR2/NECTIN2,2
GO:0006925,GO:0006925,inflammatory cell apoptotic process,2/126,22/18800,0.0094298844834405,0.0465538311595258,0.028525454687615,IL6/ST6GAL1,2
GO:0010888,GO:0010888,negative regulation of lipid storage,2/126,22/18800,0.0094298844834405,0.0465538311595258,0.028525454687615,IL6/ITGAV,2
GO:0035584,GO:0035584,calcium-mediated signaling using intracellular calcium source,2/126,22/18800,0.0094298844834405,0.0465538311595258,0.028525454687615,CCL20/VCAM1,2
GO:0071305,GO:0071305,cellular response to vitamin D,2/126,22/18800,0.0094298844834405,0.0465538311595258,0.028525454687615,BGLAP/FGF23,2
GO:0045664,GO:0045664,regulation of neuron differentiation,5/126,192/18800,0.0095281881213239,0.0466621219232092,0.0285918089101484,B2M/DLL1/EPO/NBL1/NOTCH3,5
GO:0031334,GO:0031334,positive regulation of protein-containing complex assembly,5/126,194/18800,0.0099355075377633,0.0482694800919045,0.029576703632363,CXCL13/LMOD1/OCLN/TFRC/VEGFA,5
GO:0043547,GO:0043547,positive regulation of GTPase activity,6/126,272/18800,0.0100928650527045,0.048956011567252,0.0299973698160878,AGRN/CCL14/CCL20/CXCL13/EPHA2/THY1,6
GO:0120032,GO:0120032,regulation of plasma membrane bounded cell projection assembly,5/126,195/18800,0.010143591901029,0.0490461155151181,0.030052580225586,AGRN/EPHA2/OCLN/PALM/YAP1,5
